Ocular Therapeutix Inc

NASDAQ:OCUL

12.21

-0.31 (-2.48%)

7:26:17 PM EDT: $12.11 -0.10 (-0.82%)

Market Cap (Intraday)	2.07B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$14.48 Million
Adjusted EPS	-$0.38

See more estimates

10-Day MA	$12.27
50-Day MA	$11.28
200-Day MA	$8.85

See more pivots

Ocular Therapeutix Inc Stock, NASDAQ:OCUL

15 Crosby Drive, 15 Crosby Drive, Bedford, Massachusetts 01730

United States of America

Phone: +1.781.357.4000

Number of Employees: 274

http://www.ocutx.com

Description

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.